首页> 外文期刊>Hepatitis Monthly >LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG HIV-POSITIVE PATIENTS: DATA FROM A LARGE-SCALE COHORT STUDY IN ISTANBUL, TURKEY
【24h】

LOW PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG HIV-POSITIVE PATIENTS: DATA FROM A LARGE-SCALE COHORT STUDY IN ISTANBUL, TURKEY

机译:HIV阳性患者中丙型肝炎病毒感染率低:来自土耳其伊斯坦布尔大规模队列研究的数据

获取原文
       

摘要

Background: Rate of coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) varies in different countries. This may be attributable to common transmission routes as well as social, economic and cultural factors.Objectives: The purpose of this study was to investigate the prevalence and risk factors of HCV infection among HIV-positive patients in Istanbul, Turkey.Patients and Methods: Since January 2006 to November 2013, 949 HIV-positive patients that were enrolled in this study by ACTHIV-IST (Action Against HIV in Istanbul) Study Group, which consists of five centers to follow up HIV-positive patients in Istanbul. Epidemiologic and clinical data were collected retrospectively from medical records and were transferred to an HIV database system.Results: Among 949 patients, 84% were men and the mean age was 37.92 ± 11.54 years (range, 17-79). The most frequent route of transmission was heterosexual intercourse (48.8%), followed by men having sex with men (30.5%). Only nine patients (0.9%) had history of injection drug use (IDU). The prevalence of HIV/HCV coinfection was 0.9% (9:949). The IDU rate was 44.4% (4:9) in patients with HIV/HCV coinfection (three of them were not Turkish citizens), whereas this rate was only 0.6% (5:881) in patients with only HIV infection (P Conclusions: Prevalence of HIV/HCV coinfection is considerably low in Turkey. The extremely rare prevalence of IDU might have a role in this low prevalence.
机译:背景:在不同国家,与人类免疫缺陷病毒(HIV)和丙型肝炎病毒(HCV)的合并感染率不同。目的:本研究旨在调查土耳其伊斯坦布尔的HIV阳性患者中HCV感染的患病率和危险因素。自2006年1月至2013年11月,ACTHIV-IST(伊斯坦布尔反艾滋病行动)研究组招募了949名HIV阳性患者,该研究小组由五个在伊斯坦布尔随访的HIV阳性患者中心组成。结果:从病历中回顾了流行病学和临床资料,并将其转移到HIV数据库系统中。结果:在949名患者中,男性占84%,平均年龄为37.92±11.54岁(范围17-79岁)。最常见的传播途径是异性性交(48.8%),其次是与男性发生性关系的男性(30.5%)。只有9名患者(0.9%)有注射药物使用史(IDU)。 HIV / HCV合并感染的患病率为0.9%(9:949)。 HIV / HCV合并感染患者中的IDU率为44.4%(4:9)(其中三人不是土耳其公民),而仅HIV感染患者的IDU率仅为0.6%(5:881)(P结论:在土耳其,HIV / HCV合并感染的患病率很低,极少见的IDU患病率可能与这种低患病率有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号